AAAAAA
Results:
1-20
|
Results: 20
Authors:
Junghanss, C
Leithauser, M
Wilhelm, S
Kleine, HD
Knopp, A
Decker, S
Alscher, A
Casper, J
Kohne, CH
Freund, M
Citation: C. Junghanss et al., High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize, ANN HEMATOL, 80(2), 2001, pp. 96-102
Authors:
Kohne, CH
Grothey, A
Bokemeyer, C
Bontke, N
Aapro, M
Citation: Ch. Kohne et al., Chemotherapy in elderly patients with colorectal cancer, ANN ONCOL, 12(4), 2001, pp. 435-442
Authors:
Lorenz, M
Mueller, HH
Mattes, E
Gassel, HJ
Junginger, T
Saeger, HD
Schramm, H
Staib-Sebler, E
Vetter, G
Heinrich, S
Kohne, CH
Citation: M. Lorenz et al., Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas, ANN ONCOL, 12(3), 2001, pp. 321-325
Authors:
Petrowsky, H
Sturm, I
Graubitz, O
Kooby, DA
Staib-Sebler, E
Gog, C
Kohne, CH
Hillebrand, T
Daniel, PT
Fong, Y
Lorenz, M
Citation: H. Petrowsky et al., Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases, EUR J SUR O, 27(1), 2001, pp. 80-87
Authors:
Benter, T
Teichgraber, UKM
Kluhs, L
Papadopoulos, S
Kohne, CH
Felix, R
Dorken, B
Citation: T. Benter et al., Anatomical variations in the internal jugular veins of cancer patients affecting central venous access - Anatomical variation of the internal jugularvein, ULTRASC MED, 22(1), 2001, pp. 23-26
Authors:
Thirion, P
Piedbois, P
Buyse, M
O'Dwyer, PJ
Cunningham, D
Man, A
Greco, FA
Colucci, G
Kohne, CH
Di Costanzo, F
Piga, A
Palmeri, S
Dufour, P
Cassano, A
Pajkos, G
Pensel, R
Aykan, NF
Marsh, J
Seymour, T
Citation: P. Thirion et al., Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer, BR J CANC, 84(5), 2001, pp. 611-618
Authors:
Minsky, BD
Kohne, CH
Greco, C
Citation: Bd. Minsky et al., Neo-adjuvant therapy, MODERN MANAGEMENT OF CANCER OF THE RECTUM, 2001, pp. 51-61
Authors:
Minsky, BD
Kohne, CH
Greco, C
Citation: Bd. Minsky et al., Postoperative adjuvant combined modality therapy, MODERN MANAGEMENT OF CANCER OF THE RECTUM, 2001, pp. 127-133
Authors:
Lorenz, M
Heinrich, S
Staib-Sebler, E
Kohne, CH
Wils, J
Nordlinger, B
Encke, A
Citation: M. Lorenz et al., Regional chemotherapy in the treatment of advanced pancreatic cancer - is it relevant?, EUR J CANC, 36(8), 2000, pp. 957-965
Authors:
Kohne, CH
Wils, JA
Wilke, HJ
Citation: Ch. Kohne et al., Developments in the treatment of gastric cancer in Europe, ONCOLOGY-NY, 14(12), 2000, pp. 22-25
Authors:
Kohne, CH
Peters, GJ
Citation: Ch. Kohne et Gj. Peters, UFT: Mechanism of drug action, ONCOLOGY-NY, 14(10), 2000, pp. 13-18
Authors:
Kohne, CH
Citation: Ch. Kohne, Irinotecan - Therapeutic options in the treatment of gastric cancer, ONKOLOGIE, 23, 2000, pp. 37-39
Authors:
Kohne, CH
Casper, S
Freund, M
Citation: Ch. Kohne et al., Results with irinotecan in gastric carcinoma, ONKOLOGIE, 23, 2000, pp. S23-S25
Authors:
Kretzschmar, A
Reichardt, P
Thuss-Patience, PC
Hohenberger, P
Benter, T
Dorken, B
Kohne, CH
Citation: A. Kretzschmar et al., Weekly 24-hour infusion of high-dose 5-fluorouvacil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer, ONCOL-BASEL, 59(1), 2000, pp. 14-17
Authors:
Lorenz, M
Muller, HH
Staib-Sebler, E
Vetter, G
Gog, C
Petrowsky, H
Kohne, CH
Citation: M. Lorenz et al., Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma, LANG ARCH S, 384(4), 1999, pp. 328-338
Authors:
Daniel, PT
Sturm, I
Wolff, G
Petrowsky, H
Kohne, CH
Hillebrand, T
Dorker, B
Lorenz, M
Citation: Pt. Daniel et al., Analysis of the p53/BAX pathway: Low BAX expression is a negative prognostic factor in patients with resected liver metastases of colorectal adenocarcinoma, LANG ARCH S, 1999, pp. 163-169
Authors:
Armand, JP
Cunningham, D
van Cutsem, E
Misset, JL
Kohne, CH
Citation: Jp. Armand et al., Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies, ANTI-CANC D, 10, 1999, pp. S5-S12
Authors:
Sturm, I
Kohne, CH
Wolff, G
Petrowsky, H
Hillebrand, T
Hauptmann, S
Lorenz, M
Dorken, B
Daniel, PT
Citation: I. Sturm et al., Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases, J CL ONCOL, 17(5), 1999, pp. 1364-1374
Authors:
Vanhoefer, U
Harstrick, A
Kohne, CH
Achterrath, W
Rustum, YM
Seeber, S
Wilke, H
Citation: U. Vanhoefer et al., Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 907-913
Authors:
Peters, GJ
Kohne, CH
Citation: Gj. Peters et Ch. Kohne, Fluoropyrimidines as antifolate drugs, CANC DRUG, 1999, pp. 101-145
Risultati:
1-20
|